Lenakast 10mg Capsule

Lenakast 10mg Capsule

Prescription requiredRx Required

Salt Composition: Lenalidomide

Expiry Date: 01/2028

Special offer

Buy at $20.47

$20.47

Inclusive of all taxes

30 capsule(s) in a bottle

About The Product

Blood Cancer

Description

Lenakast 10mg Capsule is an immunomodulatory drug derived from thalidomide as it contains active ingredient Lenalidomide. It is a prescription-based anticancer medicine used to treat Multiple Myeloma, Myelodysplastic Syndromes, and Mantle Cell Lymphoma.

This medicine contains immunomodulatory and antiangiogenic properties, and it works by affecting the functioning of the immune system & slowing down the growth of cancer cells. Take it in the exact dosage prescribed by the doctor.​

Uses

  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Mantle Cell Lymphoma

Side Effects

Like any other anticancer medicine, Lenakast 10mg Capsule also has some adverse effects on the body, and most of them are manageable without special medical attention.

Some common side effects include:

  • Nausea
  • Rash
  • Headache
  • Breathlessness
  • Dizziness
  • Fatigue
  • Decreased white blood cell count (neutrophils)
  • Joint pain
  • Itching
  • Diarrhea
  • Low blood platelets
  • Peripheral edema
  • Cough
  • Back pain
  • Upper respiratory tract infection
  • Decreased appetite
  • Nasopharyngitis (inflammation of the throat and nasal passages)

Seek medical attention immediately in case of any severe side effects.

How To Use

  • The dosage of the capsule is usually decided by the doctor as per the patient's health condition, stage & type of cancer. Lenakast 10mg Capsule should be swallowed as a whole with water. It should not be crushed, chewed, or cut.
  • In case you experience symptoms of overdose, immediately call your doctor or any other medical emergency helpline.​​

How It Works

  • Lenakast 10mg Capsule is an anti-cancer medication. It works by enhancing the immune system's functioning, which indirectly attacks the cancer cells. It prevents the growth of new blood vessels within the tumor.
  • It also restricts the production of chemical messengers (cytokines and growth factors), which are responsible for the growth of cancer cells.​​

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Lenakast 10mg Capsule, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms
Pregnancy
Do not take Lenakast 10mg Capsule without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Breast Feeding
Breastfeeding women should discuss the potential risks and benefits of the Lenakast 10mg Capsule with their healthcare provider before starting treatment.
Driving
Lenakast 10mg Capsule may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Kidney
Share your medical history with the doctor before starting the Lenakast 10mg Capsule. Do not take it without consulting a doctor if you have any kidney related issue.
Liver
Share your medical history with the doctor before starting the Lenakast 10mg Capsule. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

Lenakast 10mg Capsule is an anti-cancer medication, prescribed for the treatment of Multiple Myeloma, Myelodysplastic Syndromes, and Mantle Cell Lymphoma.

References

  • Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., ... & Richardson, P. G. (2016). Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma. New England Journal of Medicine, 374(17), 1621-1634. https://pubmed.ncbi.nlm.nih.gov/27119237/
  • Krönke, J., Udeshi, N. D., Narla, A., Grauman, P., Hurst, S. N., McConkey, M., ... & Ebert, B. L. (2014). Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science, 343(6168), 301-305. https://pubmed.ncbi.nlm.nih.gov/24292625/
  • Gribben, J. G., Fowler, N., & Morschhauser, F. (2015). Mechanisms of action of lenalidomide in B-cell non-Hodgkin lymphoma. Journal of Clinical Oncology, 33(25), 2803-2811. https://pubmed.ncbi.nlm.nih.gov/26195701/
  • McCarthy, P. L., Owzar, K., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Richardson, P. G., ... & Linker, C. (2012). Lenalidomide after stem-cell transplantation for multiple myeloma. New England Journal of Medicine, 366(19), 1770-1781. https://pubmed.ncbi.nlm.nih.gov/22571201/
  • Anderson, K. C. (2005, October). Lenalidomide and thalidomide: mechanisms of action—similarities and differences. In Seminars in Hematology (Vol. 42, pp. S3-S8). WB Saunders. https://pubmed.ncbi.nlm.nih.gov/16344099/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026